Newsroom

Press releasesResourcesIn the news
Sort
No items found.
No items found.

Press releases

View all press releases
Sort
Mar 31, 2026
Press Release
Alltrna Announces Approval to Initiate First-in-Human Clinical Trial of AP003, the First tRNA Therapeutic to Enter Clinical Trials
Sep 3, 2025
Press Release
Alltrna Appoints David Hava, Ph.D., Chief Scientific Officer to Drive Strategic Pipeline Advancement of tRNA Medicines
Jan 6, 2025
Press Release
Alltrna Appoints Dr. Nerissa Kreher as Chief Medical Officer to Advance tRNA Medicines for Rare Diseases
Dec 9, 2024
Press Release
Alltrna Presents Preclinical Data Demonstrating Proof-of-Concept for First tRNA Development Candidate

In the news

View all in the news
Sort
Mar 31, 2026
Article
[ExtERNAL]
Endpoints Exclusive: First Clinical Trial of tRNA Therapy, a New Disease-Agnostic Form of Genetic Medicine, Will Start Soon
Mar 12, 2026
[ExtERNAL]
Precision Medicine Online: Alltrna Eyes First Clinical Trial for tRNA Drug Targeting Nonsense Mutations
Mar 10, 2026
Podcast
[ExtERNAL]
Pharmaphorum: Treating Genetic Disease at Scale with tRNA, with Michelle Werner
Mar 3, 2026
Article
[ExtERNAL]
Advancing RNA: Engineering Translation–How tRNA Therapeutics Expand The RNA Toolkit

Resources

View all resources
Sort
Dec 11, 2023
Article
[ExtERNAL]
BioSpace Opinion: Leveraging tRNA to Scale Genetic Medicines for Rare Diseases and Beyond
Sep 11, 2023
Publication
[ExtERNAL]
JBC Review Article: Ushering in the era of tRNA medicines
Aug 10, 2023
Article
[ExtERNAL]
Defining Stop Codon Disease to Unify Treatment for Thousands of Conditions